Cargando…

Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis

BACKGROUND: Hypoxic hepatitis (HH) is a type of acute hepatic injury that is histologically characterized by centrilobular liver cell necrosis and that is caused by insufficient oxygen delivery to the hepatocytes. Typical for HH is the sudden and significant increase of aspartate aminotransferase (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Van den broecke, Astrid, Van Coile, Laura, Decruyenaere, Alexander, Colpaert, Kirsten, Benoit, Dominique, Van Vlierberghe, Hans, Decruyenaere, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790763/
https://www.ncbi.nlm.nih.gov/pubmed/29383510
http://dx.doi.org/10.1186/s13613-018-0356-z
_version_ 1783296505215451136
author Van den broecke, Astrid
Van Coile, Laura
Decruyenaere, Alexander
Colpaert, Kirsten
Benoit, Dominique
Van Vlierberghe, Hans
Decruyenaere, Johan
author_facet Van den broecke, Astrid
Van Coile, Laura
Decruyenaere, Alexander
Colpaert, Kirsten
Benoit, Dominique
Van Vlierberghe, Hans
Decruyenaere, Johan
author_sort Van den broecke, Astrid
collection PubMed
description BACKGROUND: Hypoxic hepatitis (HH) is a type of acute hepatic injury that is histologically characterized by centrilobular liver cell necrosis and that is caused by insufficient oxygen delivery to the hepatocytes. Typical for HH is the sudden and significant increase of aspartate aminotransferase (AST) in response to cardiac, circulatory or respiratory failure. The aim of this study is to investigate its epidemiology, causes, evolution and outcome. METHODS: The screened population consisted of all adults admitted to the intensive care unit (ICU) at the Ghent University Hospital between January 1, 2007 and September 21, 2015. HH was defined as peak AST > 5 times the upper limit of normal (ULN) after exclusion of other causes of liver injury. Thirty-five variables were retrospectively collected and used in descriptive analysis, time series plots and Kaplan–Meier survival curves with multi-group log-rank tests. RESULTS: HH was observed in 4.0% of the ICU admissions at our center. The study cohort comprised 1116 patients. Causes of HH were cardiac failure (49.1%), septic shock (29.8%), hypovolemic shock (9.4%), acute respiratory failure (6.4%), acute on chronic respiratory failure (3.3%), pulmonary embolism (1.4%) and hyperthermia (0.5%). The 28-day mortality associated with HH was 45.0%. Mortality rates differed significantly (P = 0.007) among the causes, ranging from 33.3% in the hyperthermia subgroup to 52.9 and 56.2% in the septic shock and pulmonary embolism subgroups, respectively. The magnitude of AST increase was also significantly correlated (P < 0.001) with mortality: 33.2, 44.4 and 55.4% for peak AST 5–10× ULN, 10–20× ULN and > 20× ULN, respectively. CONCLUSION: This study surpasses by far the largest cohort of critically ill patients with HH. HH is more common than previously thought with an ICU incidence of 4.0%, and it is associated with a high all-cause mortality of 45.0% at 28 days. The main causes of HH are cardiac failure and septic shock, which include more than 3/4 of all episodes. Clinicians should search actively for any underlying hemodynamic or respiratory instability even in patients with moderately increased AST levels.
format Online
Article
Text
id pubmed-5790763
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-57907632018-02-08 Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis Van den broecke, Astrid Van Coile, Laura Decruyenaere, Alexander Colpaert, Kirsten Benoit, Dominique Van Vlierberghe, Hans Decruyenaere, Johan Ann Intensive Care Research BACKGROUND: Hypoxic hepatitis (HH) is a type of acute hepatic injury that is histologically characterized by centrilobular liver cell necrosis and that is caused by insufficient oxygen delivery to the hepatocytes. Typical for HH is the sudden and significant increase of aspartate aminotransferase (AST) in response to cardiac, circulatory or respiratory failure. The aim of this study is to investigate its epidemiology, causes, evolution and outcome. METHODS: The screened population consisted of all adults admitted to the intensive care unit (ICU) at the Ghent University Hospital between January 1, 2007 and September 21, 2015. HH was defined as peak AST > 5 times the upper limit of normal (ULN) after exclusion of other causes of liver injury. Thirty-five variables were retrospectively collected and used in descriptive analysis, time series plots and Kaplan–Meier survival curves with multi-group log-rank tests. RESULTS: HH was observed in 4.0% of the ICU admissions at our center. The study cohort comprised 1116 patients. Causes of HH were cardiac failure (49.1%), septic shock (29.8%), hypovolemic shock (9.4%), acute respiratory failure (6.4%), acute on chronic respiratory failure (3.3%), pulmonary embolism (1.4%) and hyperthermia (0.5%). The 28-day mortality associated with HH was 45.0%. Mortality rates differed significantly (P = 0.007) among the causes, ranging from 33.3% in the hyperthermia subgroup to 52.9 and 56.2% in the septic shock and pulmonary embolism subgroups, respectively. The magnitude of AST increase was also significantly correlated (P < 0.001) with mortality: 33.2, 44.4 and 55.4% for peak AST 5–10× ULN, 10–20× ULN and > 20× ULN, respectively. CONCLUSION: This study surpasses by far the largest cohort of critically ill patients with HH. HH is more common than previously thought with an ICU incidence of 4.0%, and it is associated with a high all-cause mortality of 45.0% at 28 days. The main causes of HH are cardiac failure and septic shock, which include more than 3/4 of all episodes. Clinicians should search actively for any underlying hemodynamic or respiratory instability even in patients with moderately increased AST levels. Springer International Publishing 2018-01-30 /pmc/articles/PMC5790763/ /pubmed/29383510 http://dx.doi.org/10.1186/s13613-018-0356-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Van den broecke, Astrid
Van Coile, Laura
Decruyenaere, Alexander
Colpaert, Kirsten
Benoit, Dominique
Van Vlierberghe, Hans
Decruyenaere, Johan
Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis
title Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis
title_full Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis
title_fullStr Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis
title_full_unstemmed Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis
title_short Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis
title_sort epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790763/
https://www.ncbi.nlm.nih.gov/pubmed/29383510
http://dx.doi.org/10.1186/s13613-018-0356-z
work_keys_str_mv AT vandenbroeckeastrid epidemiologycausesevolutionandoutcomeinasinglecentercohortof1116criticallyillpatientswithhypoxichepatitis
AT vancoilelaura epidemiologycausesevolutionandoutcomeinasinglecentercohortof1116criticallyillpatientswithhypoxichepatitis
AT decruyenaerealexander epidemiologycausesevolutionandoutcomeinasinglecentercohortof1116criticallyillpatientswithhypoxichepatitis
AT colpaertkirsten epidemiologycausesevolutionandoutcomeinasinglecentercohortof1116criticallyillpatientswithhypoxichepatitis
AT benoitdominique epidemiologycausesevolutionandoutcomeinasinglecentercohortof1116criticallyillpatientswithhypoxichepatitis
AT vanvlierberghehans epidemiologycausesevolutionandoutcomeinasinglecentercohortof1116criticallyillpatientswithhypoxichepatitis
AT decruyenaerejohan epidemiologycausesevolutionandoutcomeinasinglecentercohortof1116criticallyillpatientswithhypoxichepatitis